• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Suven Life Sciences Limited — Board Meeting, 29-01-2026: Outcome of Board Meeting

    29-01-2026 | 01:04 pm

    Suven Life Sciences' Board approved Q3 and nine-month financial results, revealing consolidated net losses of ₹101.92 Cr and ₹230.75 Cr, respectively. The company also allotted 44.78 lakh shares, raising ₹60 Cr from warrant conversions, and appointed a new Company Secretary.

    No comments yet. Be the first to comment!

    All announcements from Suven Life Sciences Limited